NCT01960686 - RSV F Dose-Ranging Study in Women | Biotech Hunter

Enrollment

720

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL

Low dose RSV F Antigen

BIOLOGICAL

High dose RSV F Antigen

BIOLOGICAL

Dose 1 of Aluminum Adjuvant

BIOLOGICAL

Dose 2 of Aluminum Adjuvant

BIOLOGICAL

Dose 3 of Aluminum Adjuvant

BIOLOGICAL

Dose 4 of Aluminum Adjuvant

BIOLOGICAL

Placebo

Trial Locations (10)

Wake Research Associates, Raleigh

Coastal Carolina Research, Mt. Pleasant

Clincal Research of Atlanta, Stockbridge

QPS Bio-Kinetic, Springfield

Johnson County Clin-Trials, Lenexa

Research Across America, Dallas

Clinical Trials of Texas, San Antonio

Advanced Clinical Research, Boise

Jean Brown Research, Salt Lake City

Diablo Clinical Research, Walnut Creek